Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]

NCT01846416

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • HonorHealth Research Institute - Pima Center Scottsdale, Arizona, United States
  • Stanford University/Lucile Packard Children's Hospital Palo Alto, California, United States
  • The Angeles Clinic and Research Institute, Santa Monica Office Santa Monica, California, United States
  • University Of Colorado Aurora, Colorado, United States
View all 31 locations
View Trial Details
Completed

A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer

NCT01497873

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Chungbuk University Hospital Daegu, South Korea
  • Keimyung University Dongsan Center Daegu, South Korea
  • National Cancer Center Goyang, South Korea
  • Asan Medical Center Seoul, South Korea
View all 14 locations
View Trial Details
Completed

Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)

NCT02038647

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Los Angeles, California, United States
  • Sacramento, California, United States
  • New Haven, Connecticut, United States
  • Washington D.C., District of Columbia, United States
View all 61 locations
View Trial Details
Completed

Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

NCT02208843

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Clinical Research Center, Alexandria University Hospital Alexandria, Egypt
  • National Cancer Institute, Cairo University Cairo, Egypt
  • Kasr Al Ainy Hospital Cairo, Egypt
  • Nilai Medical Centre Kampung Baharu Nilai, Malaysia
View all 21 locations
View Trial Details
Completed

A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer

NCT02860780

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations
  • Carolinas Medical Center Charlotte, North Carolina, United States
  • Sarah Cannon Research Institute SCRI Nashville, Tennessee, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cologne, Germany
View Trial Details
Completed

A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer

NCT00789373

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Adelaide, South Australia, Australia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankston, Victoria, Australia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wendouree, Victoria, Australia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aalst, Belgium
View all 68 locations
View Trial Details

Related conditions